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Differential expression of intercellula~' adhesion mol-
ecule-1 (ICAM-1) in the epidermis plays a critical role 
in the regulation of cutaneous inflalllmation, immu-
nologic reactions, and tissue repair. Transcriptional 
upreguJation of ICAM-l in response to interferon-y 
(IFNy) occurs through a palindromic response ele-
ment pIyRE. pIyRE is homologous to IFNy-activated 
sequences, which bind to tyrosine phosphorylated 
members of the transcription facto.r family known as 
signal transducers and activators of transcription 
(STAT). The importance of tyrosine phosphorylation 
events in the STAT pathway led us to investigate the 
effect of the protein tyrosine phosphatase inhibitor, 
) pervanadate, on ICAM-l expression. We show that 
treatment of A431 cells and hu~nan keratinocytes 
with pervanadate stimulates protein complex forma-
tiO~l on plyRE in a tiIne- and concentration-depen-
I Il ter e llular :.dhes io n m o lecule- 'I (I CA M-l) is a tran sm e ll1-bran e g lycoprotein tha.t ll1e'diates se lective cellul ar adhes io n and p lays a key ro le 111 the regu latlon o f cutaneOll S IIlflalll-mati OIl, imll"lull o logic respo nses , and woun d rep.lir . T he inte ractio n between l CAM-l and its ligands , /32-integrins 
lyn,phocyte fun ctio ll-associated an tigen 1 (M arli.1l and Sprin ge r, 
1987) alld M ,le-I (Diamond eI ai, 199 1) , has been sho wn to be 
critica l fo r OJ Ilun.b cr of adhesion eve nts am o llg le ukocytes and 
between le ukocy tes aud o th e r cell types (D ustin ;lt1d prin ger , 
1988) . ICA M - I ca n be tra nscripti o naJJ y llpwglli ated in a variety of 
ce ll s, in c lu d ill g ke r'lti ll ocytes (D usti ll 1'1 ai, 1988: G riftiths c( ai, 
1989) . upo n srimul atio ll with lipo pol ysacc haride, phorbol esters, o r 
infla mmatory cy tokil1 es, such as ill te rfe roll-y (IFNy), tumor n ecro-
sis facto r-a, and in te rl e ukin-1 (D ustin ci al. J 986). Upregul atio n of 
ICAM- 'I express io n 0 11 epide rmal keratinocytes is found in man 
diverse inflammatory skin d iseases, in clu ding all e rgic colltact de r-
mati ti s, psorias is, a ll d liche n plallu s (S inger 1'1 ai, J 989; Y",jlsgaard c ( 
ai, 1 989) . T h e regulati o n of ICA M - I ex press io n in th e skin may 
en h a nce the recrui tment and loca li zation o r le ukocytes as w e ll as 
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ony-activated se'luence: ISKE, in tcrferon-sti.llula ted response clement: 
GBP. guan yla te binnin g protein . 
dent manner. As demonstrated by mobility supershift 
assays, the pervanadate-stinlulated complex is simi-
lar to the IFNy-stimulated complex and contains 
Stat1. Pervanadate treatm.ent also led to an increase 
in overall protein tyrosine phosphorylation and phos-
phorylation of Stat1, as well as the subsequent in-
crease in ICAM-l mRNA and cell surface protein 
levels. These data show that pervanadate can miInic 
each step in the IFNy-medjated pathway leading to 
ICAM-l expression, demonstrate the ability of a 
pharmacologic agent to bypass the standard cyto-
kine-receptor interaction required for increased 
ICAM-l expression, and emphasize the importance 
of protein tyrosine phosphatases and protein tyrosine 
kinases in mediating inflammatory responses in the 
skin. Key lVords: il/tel:{eroll-y/cell ndllesiol//gel/e eXl'l'essiotl/ 
siglin.! tr(//Isd"ctioll. ] II/vest D er/l/n(()/ 108:295-301, 1997 
enhance the ph ys ica.! intera ctio ll betweell activated leukocyte pop-
ulat.i o ns and keratinocytes. 
I FNy is aT-lymphocyte-derived c)'tokill e that affects a va ri e ry of 
ce lls by its illlllluno m od uia to ry activi ti es . IFNI' exerts its efFects by 
binding to spe ifi c receptors on th e cell m e mbrane and ini t iati ng a 
sig nal transduc tioll pathway that leads to the inductio n of gene 
expressio n . It was recendy shown that the lCAM -l pro m oter 
con tai ns a palindro mi c sequell ce 5 ' -TTT CGGGAAA-3 ' (p l yRE) 
betw een lluc1eotides - 76 to - 66 that confe rs respo n siveness to 
lFN y in primary airway e pi the lial ce ll s (Look (,( al. 19(4) a ll d 
l-IepGZ 11l!patoma ce ll s (Ca lde llhovell 1'1 ai, 1994). T he ICAM - l 
pl yR E is ho m o logous to th e IFNy-ac ti vated-seqne n cc (GAS) ti rst 
described in the promote r of human guanl yla re-b indin g prote in 
rGBP, (Decker r l ai, 1991)]' T he GAS c le m e n t binds ro a m ember 
of the STAT (s ig nal rrallsdu cers alld activators of transcrip tioll) 
fa mil y of cytophlsmi c transcripti o n fa cto rs. 
Tyr osill e phosphorylation of the STAT pro teins is required fo r 
bindin g to the ir respec ti ve respo nse clements (S huai 1'( ai, 1993) . 
Stat I ty rosi ne phosph o ry latio n is m ed ia ted th roug h the in teraction 
between the ty rosin e-phosph o rylated I FN Y recepto r ( lgarashi 1'1 al. 
1994) and two m embe rs of the tyrosin e kinase f.1 mil y, Jallus 
kina se- l OAK I) and J AK2 (Mulle r cI (I I. 1993 ; Watl in g ('I ai , 19(3). 
Tyros in e phospho rylation alld ac ti vatio ll ofJAKl and JAK2 occurs 
rapidly in resp o nse to IFN I' bin cling to its receptor and lea ds to th e 
phosph o rylati on and activa tio n o f Stat I (S huai el ti l, '1993 ) . 1n m ost 
ill st:ll1ces, ac tivated Stat l the n hOl1lodime rizes d11'Ough its src-
hOlll o logy-Z (S I-I 2) do mains to fo rm II: N y-activatio n f.1cto r (S hu ai 
el al. 1994) , w hich trans locates to the nucleus and ini tiates gene 
tra ns ripti o n by billd in g to GA sites (Decke r cI al. 199 1; Le w c( al. 
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1 9Y I). The parti c ipation of tyrosine phosph orylatio n of mul t ipl e 
STAT protein s is a lso evident in IFNa-tre ated ce ll s in w hic h Statl 
and Stat2 become tyros in e phospho l·)dated and co mbin e w ith the 
DNA recognition n o n-STAT protein p48 to form th e IFN-stil1111-
la ted ge n e fa c tor 3-0' (ISGF3 0') , w hic h stimu lates ge ll e tra n scrip t io n 
via the IFNa-stimula ted res p o n se c lemen t IISRE. (Fu ct ai, 1990) ]. 
T h e importance of protein ty rosi n e phosphorylation events in 
this pathway le d u s to investig a te th e role of protein tyrosin e 
phosphatases in IFN-y-s ignaling and l CAM-·1 gen e express io n . W e 
fo un d tha t tr eatm e n t of e piderma l carcino ma A431 ce ll s and hu man 
keratin o cytes with th e potent prote in tyros in e phosphatase inhibi-
tor, pervanadate, provides all of the n ecessa ry signals and m o difi-
catio n s of tran scrip t io nal pl"Otein s for DNA b in din g to th e IC AM-1 
pI-yI~E and subsequent l CAM-1 mR..NA and prote in ex pression. 
These studies demons t rate th at the regul atio n of sign al tra nsd uc t io n 
even ts and th e indu ct io n of IC AM-l gene ex pressio n are critica lly 
depe nde nt upon a physio logic b alance and continuoll s functiona l 
readin ess of specifi c tyros ine kinases an d phosphatases tha t m ediate 
IFN I' e ffects in ke rati n ocytes. 
MATER.JALS AND METHODS 
Cell Culture T he hum an epidermoid squamous el l carcinoma line A43 1 
(Giard ('I (II , 1973) was obtained fro m the Ame ri can Type C ul ture Collec-
tio ll (Rockvi lle, MD) and growlI in Dul becco 's modi fied Eagle medium 
(G ill 0-13R..L. Ga ithers burg. MD) as described previously (Ca ughl1lall cl (I I, 
1990) . I-[uman kerati nocytes were iso lated frol11 neonata l foreskin s (Boyce 
and Hal11 . 1985) at the Emory Skjn Diseases R esearch Center and cul tured 
in Keratin ocyte Growth Med ium (C lonetics Corp .. Sa n Diego. CAl sup-
plemented with bovine p,ituitary exlTact. 
Electrophoretic Mobility Shift Assays (EMSA) Ce ll s were tre"ted 
with either human recomhinant IFNI' (R & D Sys tems, M.inn eapo li s, MN). 
o r H 20 , and Na, VO". and nucl ear ex tr"cts were prepared exact ly as 
desc ribed previously (Gille cl al. 1996). T he p lyR..E o ligonucl eotide was 
synthes ized to enco l11p ass the l FNy-responsive site (in IUl/dF,rl') fo und 
b .twccll positions - 76 and - 66 bp of the human IC AM- I promote r: 
5 '_CG AAG CTTTTCCGGGAAAGGATCCCGCGC-3'. The IIlIdcrlill cd 
seguence represents an unrelated tai l sequence added to serve as template 
for synthesis of the second strand. Radio labe,lcd double-stranded DNA was 
synthes ized by anneali ng an o ligonucleotide complementary to the 3' end of 
the sequ ence li st.ed above (1lIIdl'rlill i'd; 5'-GCGCGGGATCC-3') and by 
extendin g the second strand with Klenow fra gment. 50 I.l.Ci ra :<2 P]dCT!'. 
unlabeled dATI' , dGTP, ;lI1 d dTTP fo llowed by the add ition of unlabel ed 
dCT!' to ensure completion of the second strand . All o ligonucleotides were 
synth esized by the Emory University Microchel11 ica l Facility. T he DNA-
binding reaction W<lS perform ed as described prev iously (G ille'" al. 1996) 
using 5 IJ..g of nuclear prote in extrac t with o r w ithou t l O-fo ld 11101o:I r excess 
o f cold competitor DNA o r 1- 10 I.ti of "ntibody. Competitor and antibody 
were added 20 min prio r to the addi tion of the probe. Anti-Stat·1 (ISGF3 
p9 I 184), Stat2 (ISGF3 p113), Stat3 (A PR.!:). Sta t4 , StatS (MGF). and Stat6 
(lL-4-Stat) antibod ies were obtained (i·OIll Transduction Laboratories (Lex-
ington, KY). A Stat3 (APH .. F) alltibod )' was also obtained from Santa C ruz 
Bi o techno logy. Inc. (Santa C ruz, CAl· DNA-bindin g reactions were sepa-
ra ted by 4'Y" native- po lyacrylam ide gel e lectro phores is for 4 - 16 h at 
100- '120 V / ·1 ()-12 Amp. Ge ls were subseq uentl y dri ed and auto radiograph), 
performed. These and all subsequent autorad iographs were scanned On a 
LaCie scanlle r L1 sing Adobe Photoshop so ftwa re (Adobe Systems, Inc .. 
M Olill ta in Vic\-", C A). T he di g iti zed irnagcs ,-vere then ir Tl po rtcd into a 
Mad raw Pro (Claris Corp., Sa nta Clara. C Al Iile w here they were labeled 
and prin ted on a hi gh-resoluti on lase r prin ter. 
WesterJl Blot Analysis A43 1 ce ll s were treated with either IFN I', Or 
H , 0 2 and NaJ VO". and who le ce ll extracts were prepared. Equal amoun ts 
of proteill (20 f.Lg) were separated by '10';";, sodi um dodecyl sulfate-
polyacrylamide gel electrophoresis, transfern:d to Il.i troce llulose membrane. 
afte r \vhi c h \~/ cs (c ril blot ana lys is waS pcrfo rlncd lI sin g a 111onoclona l 
anti-Stat1 (ISG I:3 p9 1/ 84) antibody (Tra ll sduction Laboratories) or a 
monoclonal anti-phosphotyrosin e antibody PY20 (Santa C ruz B iotechnol-
ogy. Inc.). After incubation with horseradish peroxidase- conju gated sec-
on dary antibody. the bl ots were developed using 13M chemi lu mi ll escence 
Blo tting Substrate (Boehringer Man u!Jeim. Indianapo lis. IN). 
Northern Blot Analys is T ota l ce ll ular R .. NA was iso lated anel ana lyzed 
from ce ll s usin g IlNA zol B (B iotecx L"boratories, Houston. TX). forma l-
dehyde/;'garose ge l electrophoresis. and bl otti ng to Nytra n plus melll br"nes 
(Schleicher & Schuell . Keelle. NH). RNA was cross- li nked to the l1I elll -
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b,.,lIles using the UV Strata lin ke r (Str"t"gelle. La J o ll a. CAl then pre-
hyb ridi zed at 65 °C for 30 min in R ap id-h),b buffer (A lliersh"l11 Life Science. 
ArlingtO Il Heights. IL). Radio labe ling of the probe human IC AM-1 [0.67 
kb 5 1111 fragment of the ICA M-:J eDNA (St" un to n el al. 1988)J was 
performed usillg the ra ndom- primer label illg kit Ilediprimc (Amcrsham) 
usin g 50 f.LC i [a-n P]dCTP. H ),bridization was performed at 65 °C fo r 2 h in 
Rap id-hyb buffer containing approximatel y I X 10" Cplll per 1111 of th e 
J2P_labeled probe. Membranes were washed twice ill 0.1 % SDS. 0.1 X 
sod ium citra telchlo ride bufFer (1 X = 0. 15 M NaC I, 15 mM sod iul11 citra te) 
for 20-30 l11in at G5°C, and autoradiography was then perfo rmed . 
Enzymc-Linkcd ImmLJnosorbcnt Assay (ELISA) Cell s were stil11l1-
lal·cd with IFNI'. Or H20 , and N;" VO.,. fo r 12 h. thell incubated for 1 h 
with a monoclona l all ti-ICA M-1 an ti body 184 hi O. (Makgoba "I ai, "J 988)] 
di lu ted 1 :30. fo ll owed by a 1-h ill cuba tion with horse radish perox idasc-
cOlljugated goat anli-mou se IgG (Bio-Rad. Hercules, CAl d il uted") :500 . 
After was h;Jlg, bindillg was ,messed by additioll of ,I f.Lg per 11'1 1 3,3 ' .5.5 ' -
tetra ll1 erh yl-bell zidine (S igma C hemical Co., St. Loui s, MO) "lid 0.03% 
H2 0 2. T he reaction was stopped b)' the addition of 20 f.L1 of 8 N sulfuri c 
acid , " li d plates were read on all ELI SA rcader (3 11 L; 13io-Tek Instruments , 
Winooski . VT) at 450 nm. Contro l fo r backg round was provided by 
incuba tion w ith the secondary antibod ), alone. and cO ll trol fo r specificity 
was provided by incubatio ll with all isotype-matchcd allti body against 
vascular ce ll adhes ion molecule (G ill e cl "I, ·199 6). fo llowcd by the 
horserad ish peroxidase- conjugated secolld srcp reagent. 
RESULTS 
Induction of pIl'RE Complex Formation by Pervanadate 
P e rvanadate is a poten t protei n ty ros in e ph osphatase inhibitor that 
has been shown to lead to th e acti v<ltion of tyros in e k in ases an d 
ca use an overall in crease in th e le vel of p rote in tyros in e p hosphor-
ylatio n (Helte tz et ai, ·1992). Because I FN -y signalin g in vo lves 
ac t ivation of th e tyros in e k in ases, J AK1 and J AK2 , and subsequ ent 
tyros ine phosphorylation of Stat l , we examin ed w h e tll e r pervana-
date cou ld stim ula te sign al transdu ction events typ ic <l ll y associated 
w ith the actio n of LFN I' and mimi c the induc tion of LFN -y- specifi c 
l CA M-1 gen e ex press io n . W e fi rst d etermin ed w heth e r p en ' an a-
da te cou ld stimu late nucl ea r prote in complex fo rmation on 
ICA.M-1 pI -yR.E b y ge l mobility shift assays. Sodium orthovanadate, 
although <I n exce lle nt prote in tyrosin e phospha tase inhibi tor, does 
not re adil y c ross into th e cellul <l r cytosol ill "irro. T h e additi o n of 
1-12 0 2 and Na, V0 4 to th e c ul ture m ed ium, however, lead s to th e 
formation of perva n adate and m arked ly fa c ilitates th e e ntry of 
va nadate into cells (Heffetz cl a/, 1992). As shown in F ig tA, n o 
pL-yRE-binding ac tivity was observed in nu clea r extracts harvested 
fi·o m u ntreated A43 1 cell s. Stimulation of A431 ce ll s w ith 2 50 U 
IFN I' pe r ml for 2 h res ul ted in the appea rance of a specifi c 
pl -yRE-bindin g complex , as d e m o n strated b y the loss of t lu s 
compl ex in th e p resen ce of j O-fo ld excess co ld pl -yR E. Stimularjon 
of A43 1 cell s w ith 1-1 2 0 2 an d N a3 VO~ (per va nadate) a lso res ul ted 
in the formatio n ofa specifi c pI -yRE-binding cOl11plex that was nor 
fo un d in respon se to e ith er H 2 0 2 o r N a3 VO., " lone (Fig tAl. T h e 
pl -yRE complex formed in response to perva nada te mig rate d at the 
same p ositi o n ;I S the fFN -y-stimulate d complex. A secon d compl ex: 
of less in tensity and slower m ohili ty a lso appe ared in resp o nse to 
both I FN-y and pervanadate , but thi s comp lex ha s not been found 
re produ c ib ly and was not examined furth e r in thi s study (Naik ci nl. 
1996). 
To determine whether the in du c ti o n of p i -yRE compl ex form a-
t io n by p e rva n adate a lso occurs in othe r e pithe li a l ce ll s, ge l m o bili ty 
shift assays were performed in HeLa ce lls and human keratin ocytes. 
As shown in F i g lB, pervanadate stimulate d p l -yR .. E com p lex: 
fo rm ;,ti o n in hum an keratinocytes in a con centrati o n-depende nt 
fashion . Simil ar resu lts we l·e ob tain ed in th e cervica l ca rc in o ma cell 
line l-IeLa (data not shown) . 
As show n in Fig 2A , inductio n of pl -yRE co mpl ex form ation was 
depe nd e n t on the c o ncen tration of pervanadate . Ma x im al indu ction 
(witho ut sig ni ti c allt cell toxi city) was fou n d at lOO J.LM of both 
I-i 2 0 2 and Na3 VO" and was used fo r the re mainin g ex pe riments. 
Indu ction of pl -yRE compl ex formation by pe r vanadate was a lso 
t ime-depe nde n t, w ith o nset o ccurrin g 1 5 min atler pervanadate 
addition and peak inte n sity occurring at 120 min (Fig 2B). IFN I' 
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A A431 Cells B Human Keratinocytes 
Ctl Pervanadale IFNy Competitor 
IFNy 
H20 2 + + + + ! ! 10 30 100 Comp.St .. l! Comp.St.t1! 
Figure 1. Pervanadate treatment of A431 
cells and keratillocytes stimulates complex 
formation with the ICAM-l plyRE. (A) A431 
cells were incubated with or without 250 U TFNy 
per mI . 100 /-LM H2 0 2 , 100 /-LM Na, V04 • or both 
H2 0 2 and Na, VO.1 at 100 /-LM each fo r 2 h. 
N uclear extracts were prepared . and 5 p..g rotal 
prote in were lised in an EMSA in the presence of 
a '''P-labeled pl yRE probe. Ten-fold mol"r excess 
of competing ulllabeled pT r ltE oligonucleo tide 
was added to the binding reaction as indicated. (8) 
HUI11 ;'II1 keratinocytcs were treated fo r 30 mill 
with or without 25() U IFN r per ml , or H20 2 and 
Na, VO, (pervanadate) at the indicated concellt .... -
tiO IlS. Nliciear extracts were prepared and 5 /-Lg of 
tota l proteill was used ill all EMSA ill the presellce 
of a .12P_IabcJed plyRE probe in the presence or 
abscllce of all anti-Stad antibody (Statl) or IO-fold 
molar excess of competillg ulllabeled pl r ltE oligo-
nucleotide (Comp.) as indic"ted. The slipershifi:ed 
N03V04 ...... .-~-...,.'!"""': ......... + ...... +~ 
ind u c tioll of the plyRE complex. however, occurred more rapidly 
tban pe rvanadate-induced complex formation, with onset and peak 
at 30 s afte r IFNI' trl!atment (Fig 2B). T h e differl!ll ce in onset of 
complex fo rmation may represent diffe ren ces in th e time n ecessary 
for the pe rvan;lda tl! to en tl! r thl! ce ll and achi eve effecrive intra ce l-
lular concentrations . Alternatively. the kineti cs of phosphatasl! 
in hibitio n by pervanadate m ay be distin c tl y slower than the tyros in l! 
kinase activity initi ated b y IFNI' bindin g to its cell surfa ce receptor. 
To examjne the l! ffc ct ofpe rvanadatl! o n IFN y-mediated pl yRE 
complex formation , A431 cells w ere prl!-treated with 100 fLM 
perv3nadate fo r 30 min pri o r to the addition of IFNI'. As shown in 
Fig 3, perva nadate pre-treatl1ll!1H enhan ced IFN y-rnediated plyR.E 
complex formati o n to a kvel obsl!l"ved with pervanadate treatm ent 
alone, suggesting that pe rv<1 n ,ldate trl!<lrmeu t m m"; m all y stimulatl!s 
plyRE prote in complex formation , whe reas IFNy-induced COI11-
A 
B 
H202 (pM) 
Na3V04 (pM) 
Pervanadate 
Time (min) 
o 
o 
o 5 15 30 120 
30 100 1000 
30 100 1000 
IFNy 
Time (min) 
o 0.5 5 240 480 
Figure 2. Perv"nadate treatment of A431 ceUs stimulates complex 
formation with the ICAM-l plyRE: Timc courSc and dose re-
sponse. (A) Concentration dependence. A4:1 '1 cells were incubated in the 
presen ce or absence of the indic,lted concentrations of .H 2 0 2 and No, YO, 
fo r 2 h. Nuclear extra cts were prepared alld used in an EMSA with a 
3zP_l abeled pl yR.E probe. (B) Time course. A4 31 cells were treated with or 
wi th o ut 100 /-LM perv'lIwdate ("ji pnl/eI) or 250 U IFNI' per 1111 (r(~/'f pnl/d) 
for the indica ted t il11C pe rio ds. NudcOlr 'xtrac ts were. prl..!p:\rcd and lIsed in 
an E M SA with a J2P_labeled pi r RE probe. 
tat I-conrairullg comple" is indicated by the 
pl ex formation is m ost like ly limi ted by the number of IFNI' 
receptors present. 
Sequence Specificity of the Pervanadate-Induced Complex 
Several IFN response e!l!m enrs have been fo und and can be 
separated in to three categories : (i) T he ]SI~, w hi ch binds to a 
multiprote in compl ex of Stat' 1 , Stat2, and p48 in response to IFNQ' 
(Fu el (1/ , 1<)90); (ii) T Ill! GAS e lem e nt , w hich binds to Statl 
homodimers (Dl!cker eI (1/,1 99 1; Lew <'I ai, 199 1; Shuai el ai, 1994) 
as well as othe r members of the STAT family (Schindler and 
Darne ll , 1995); and (iii) A palindromic GAS-like c le m ent. p l yl~ 
or p!l~E, w hich binds to Statl o r other STAT-like protein factors 
(Pearse el ai, 1993; Caldenhoven cl ai, 1994; H arroch cl ai, 19<)4) . 
To examine the sequence specifl it)' of the pi yR E protein complex 
formed in response to pl!rvanadate, compet.ition ana lys is was per-
form ed with o ligon ucleotides containing eith c r au ISRE, GAS, o r 
plyI~ site (Fig 4A). As shown in Fig 4B. radio l;lbe led pIyl~ 
complex formation indu ced in response to both IFN I' and pe rvan a-
date was displaced by excess unlabe led plyR E. [n other words. 
excess unlabeled plyRE compl!tcs with the radiolabeled probe for 
bindin g to prote in compl excs t ha t are formed in responsc to e ith er 
IFNI' or pc rvanadate treatmen t of the cells. Since this complex 
contains no radiolabcled probe, no shifted comple x is observed in 
these lan l!s . O ligonucl eotid·s containing scquences simi.lar to 
pI yl~, such as FcyRl , (Pearse c ( ai, 1993), IRF-1 (Sims ef ai, 
1993), and murine [CSBP (Kanno Cf ai, 1993) , all successfi tll y 
displaced binding by both the IFNy- and pe rv anadate- stimu.lated 
cellular lysates. An o ligon ucl eotide co ntaining a GAS site with 
sequence ho mology to plyRE, Ly6E (Khan e( a/, 1993) , compe ted 
Time (min) 
Pretreatment with 
pervanadate No pretreatment 
r---~~--~--~~------~---------
Figure 3. Pcrvanadate pre-treatment enhances pl'YRE complex 
fOrtllation in response to IFNI" A43 \ cells were pre-incubated with or 
with out lOO /-LM pervanadate for 30 Illin prior to stimulation with 250 U 
I FN-y per IllI for the indicated time periods. Nuclear extra ·· t $ were prepared 
and used in an EMSA with a 32 P-labclcd pl r RE probe. 
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A 
plyRE 
GBP 
FeyRl 
IRF- l 
Ly6E 
ICSBP 
6-16 
Oligonucleotides used for Competition 
CGAAGCTTTTCCGGGGAAAGGATCCCGCGC 
CGAAGCTTAGTITCATA TIACTCTAAATCGGATCCC 
CGAAGCTTTTCTGGGAAAGGATCCC 
CGAAGCTTTTCGGGGAAAGGATCCC 
GCGGATCCTTTCCTGTAAAAGCTIGC 
CGAAGCTTTTCCGAGAAAGGATCCC 
CGAAGCTTGGGAAAATGAAACTGGATCCC 
GA$-123 CGAAGCTTAGTTTCATA TIACTCGGATCCC 
8 
r---- Pervanadate ---~----- IFNy -------. 
_ 1_ GBP IRF· I ICSBP GAS 1_ cap IRF· I ICSBP GAS I pI,RE Fc:-,AI LyGE &.18 · 123 ~AE FeyR l LyeE 8-18 · 123 
Figure 4. Competition analysis of pI')'RE complex formation in 
response to pervanadate and IFNI' reveals a subset oflFN-response 
clements can compete for complex formation with pI')'RE. (A) 
Sequences of the oligonuclcotid l!s used for competition. O ligonucl eotides 
correspond to I FN-responsc clemen ts identified in the transcriptional 
regulatory regions of other genes. Bold INfers indicate pl yR£, GAS, or ISHE 
sitcs. (B) Nuclear extracts fi'om A4 3'1 ce ll s incubated without or with 100 
f1.M perva nadate (Iefi) or 250 U pcr rnl IFN I' (r(~"f) were prepared and used 
ill an EMSA with " 32P_labcled p lyH.E probe ill the presence or absence of 
tlt l! indicatl!d un labl!il!d competitor oligonucleotides. 
for b inding w ith the IFN "y- and pe rvanadate-stimulated compl ex, 
w hereas an o llgonuckotide de ri ved fi'om the prototypic GAS 
sequ ence, G BP, first described in the g uanylate-binding protein 
gene (Le w cf 11/, 199 '1) , o nl y min ima ll y competed for binding with 
the I FN"y- and pervanadate-stimulated compl ex . Neither a GBP 
GAS- containin g o ligonucleotide, w hich con ta ins only a partial GAS 
site (GAS-123), no r an ISRE-conta inin g o li gonucleotide from the 
6-16 gene (AckriU et 11/,1991) competed for binding to the pl"yRE. 
T hese studies dem on strate that pI"yRE shares features with a 
subgro up of, but not all , TFN "y-responsive c lem ents. 
Characterization of the Proteins Present in the Pervana-
date-Induced Complex To eX<lmille whether th e pe rvan adate-
induced pl "YRE-bindin g activity involves Statl or other STAT 
protein s, we performed supershift analys is. As shown in Fig SA, 
n e ithc r the 1FN"y- nor pervanadate-induced pl"yIU co mpl ex was 
shifted by anti-Stat2 o r anti-p48 antibod ies, indica ting tha t Stat2 
and p48 arc probably not in volved in p l"y1U complex formation. 
T hese results arc consistent with the il1<lbiJi ty of the ISTU - conta in-
in g o ligonucl eotide to co mpete away th e pl"yRE complex, as 
dem o nstrated above (Fig 4B). 'Wh en the anti-Statl antibody was 
added to the reaction mi xtu re . a supershifted pIilU complex was 
o bserved (Fig SA) , suggesting that Stat".! or a Statl-like prote in is a 
compone nt of the pl"YRE compl ex. Add ition of an anti -Sta t3, 
-Stat4 , -StatS, or -Stat6 antibody did n ot supershift t.he pervana-
d ate-induced pl"ylU complex (Fig SB) , indicating that none of 
tbese Stat prote in s are present in th e pl"yRE complex. T he presence 
of an an ti-Stat1 antibody in the bindin g reaction using hum an 
k eratinocyte nuclear extracts a lso resul ted in a supershjfted pJ"y'RE 
complex (Fig 1B), indica ting that A43".1 ce ll s and human keratino-
cytes (a s well as B eLa cells, data not shown) forl11 a similar complex 
on the p l"yRE in response to pe r vanadate. 
Asse mbl y of th e IFN"y-ac ti va ted tran scriptio n complexes on 
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A IFNy Pervanadate Stat1 Stat2 p48 Stat1 Stat2 
B Pervanadate 
Figure 5. The pervanadate- and IFN,),-indllced pIyRE complex 
contains Statl: Supershift analysis. (A) Nuclear cxrracts frolll A431 
ce lls in cuba ted without or with 100 f1.M pcrvalladatl! (r;g"f pal/eI) or 250 U 
pcr 1111 IFNI' ({tji 1"lIId) Wl! rl! prepared and used ill all EMSA with a 
32P_labe led pl yR.E probe ill the presence or absl!ncc of anti-Stat I. -Stat2, or 
-p48 antibodies. T he supershi fted Statl-contai lling complex is indicated by 
->. (B) Nuclear extracts from A43 1 ce lls stimulated without or with 100 f1.M 
pervanadate for 2 h were prepared and used ill an EMSA with a .l2P_labe led 
pl yKE probe in the presl!ncl! or absence of :mri-Stat3. -Stat'l, -S tarS . or 
-Statu antibodies. No supcrshifted complexes were detected. 
pl "yRE, ISRE, and GAS requires tyrosinc phosphorylation and can 
be specifically disrupted by treatm ent wi th a prote in tyros in e 
phosphatase (Igarashi ef 11/, 1993 ; Naik et 11/ , 1 (97) . To determine 
whe ther treatment of A431 ce lls und er o ur conditi o ns w ith pe r-
vanadate stimul ates prote in tyrosine phosphorylation, western blot 
ana lys is was performed with an anti-phosphotyrosine antibody. 
Treatment of A431 cells with pe rvanadate led to a substantial 
increase in the phosphotyrosine conten t of man y prote in s (Fig 6A) , 
consistent w ith its .abiJjty to inhibit protein tyrosine phosphatases 
and/or stimulate prote in ty rosine kinases. Treatm ellt with H 20 2 or 
N a, V04 a lo ne had no effect on the level of protein ty rosine 
phosphorylation (Fig 6A) . To exam in e w hether pe rvanadate also 
sti mulated phosphoryl ation of Statl, w es te rn blo t analysis was 
performed. Tyrosine-phosphorylated Statl has a hi ghe r m o lecul ar 
size 0 11 sodi um dodecyl sulfate-po lyacrylamide gel e lectrophoresis 
than unphosphoryla ted St<l t l and can be detected by a bandshift on 
western blot (Lutticken el 11 /, 1994) . As shown in Fig 6B, IFN I' and 
pervanadate treatment of A431 ce lls indu ces Stat"! activation as 
determine d by the slower migrating form of both p9 l and pS4 
Stat1. T he time course for bandshift o n w estern blot corre lates with 
the time course fo r DNA-binding ac tivi ty seell by gel mobility shj ft 
assays, with onse t of phospho rylation occurrin g within lS-20 min 
in response to pe rvanada te, and within 30 s in respo nse to IFN I' 
(data no t shown) . 
Pervanadate Induces Expression of ICAM-l mRNA The 
abilj ty of pervanadate to induce DNA-binding ac tivity on the 
ICAM-l pT"YRE suggested that it may also stimulate expression of 
the TCAM-1 gene. To test this hypothesis, NOJ·th e rn blot analysis 
using an ICAM-l pro be was performed 0 11 total RNA harves ted 
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Control Pervan. IFNy 
Figure 6. Pervanadate treatment of A431 cells stimulates protein 
tyrosine phOsphorylation and Statl phosphorylation. (A) A43 1 cell s 
we re incubated with or without H20 2 , Na1 VO." or both H20 2 and 
Na3 VO., (pervan:.da tc) for 2 h, and whole cell lysates were prepared. Equal 
amo unts of protein were separated by I D'X, sod ium dodccyl suliitte-
polyacrylamide ge l electrophoresis, and western blot analysis was performed 
using monoclonal anti-phosphotyrosine antibod)' (PY20 . San ta C ruz Bio-
technology, Inc.) and horserad ish peroxidase- conjuga ted secondary anti-
body. (B) A43 I ce ll s were trea ted with or without 100 /LM pervanadatc or 
250 U IFNy per ml for 2 h. and whole ce ll Iysates were prepared. Equal 
amo unts of protein were separated by 10% sodium dodecyl sul f.lte-
polyacrylamide ge l electrophoresis, and western blot analysis was performed 
using monoclonal anti-Statl (ISGF3 p9 1/ 84) antibody and horseradish 
peroxidase-conjugated secondary antibody. -> indica tes native Statl cx(p9 1) 
and native Statl13(p84) and phosphorylated Stat I cx(pp91) and phosphory-
lated Statl13(pp84). 
fro m pervanadate- o r IFN y- treated ce lls. As shown in Fig 7A, 
expression of th e lCAM-l gene was signi fica ntly upregulated in 
response to IFN y in a time-depend e n t fashi o n , with o nset occurring 
at 30 min. T he upregulatio n of ICAM-1 ml~A expression by 
pervanadate was a lso time-depe ndent, w ith o n set occurring at 
approximate ly 1 h and reaching leve ls similar to IFN y b y 2 h . 
Pervanadate also indu ced ICAM-1 m~A expression in human 
keratin ocytes to a level simil ar to IFNy-treated cells (Fig 7B). 
Pervanadate StinlUlates Cell- Surface ICAM-l Protein Ex-
pression To explo re whether th e induction of ICAM- l I11~A 
by pervanadate leads to an increase in protein levels, ce ll surface 
ICAM-1 express io n was m easured by ELISA usin g an anti-ICAM- l 
A B Ctl IFNy Porv. 30ml" I hr 2hr 
Ctl IFNy PlIWv.llFNy P.,..,jlfNy Peril. 
ICAM-, 
'CAM· ' 
285 285-
EIBr 
EtBr 
185 
'8S -~II •• 1I1 
Figure 7. Pcrvanadate stimulates ICAM-l mRNA expression in 
A431 cells and human keratinocytcs. (A) A431 cells were incubated 
wi thout or with 100 /LM pervanadate or 250 U IFNy per 1111 for the 
indicated time periods. Total ll...NA was prepared . and 10 /Lg were examined 
by northern blot ana lysis. Nytran membrancs were hybridized with a 
32P-Iabcled ICA M cDNA fragmc nt (1Il'pcr pnllel). A photograph of the 
ethidiu l11 bromidc (EtBr)-staincd agarose ge l is shown to dcmonstrate even 
loading (1()I ller P(lIIeI) . (B) Human kcratinocytcs were treated w ithout or with 
100 J.LM pervanadate or 25D U lFNy per ml for 4 h. and total n.NA was 
isola ted and cxam ined by northcrn blot analysis . Nytran mcmbranes were 
hybridized with a 32P-labelcd ICAM cDNA fragment (lIpper !,nIle/). A 
photograph ofthc ethidi um bromide (EtBr)-stai ll cd agamse gel is shown to 
demonstrate evcn loading (l"IIIer pn ll el). 
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F ignre 8. P ervanadate treatment of A431 cells stimnla t es expres-
sion of cell surface ICAM-l protcin_ A431 ce ll s in 96-weU tissuc culrure 
plates were incubated wi thout or with various conccntrations of H2 0 , and 
Na, VO. or 250 U TFNy pcr ml for 12 h, and ce ll surf.lce pro tein expression 
was measured by ELISA using a monoclonal anti- ICAM-l antibody. Typical 
absorbance va lues were: Contro l. 0.96; IFNy. 0.213 , and pervanadate. 
0.228. T he mean of the absorbances obtained /Tom quadruplicate samples 
was compared to the untreated, control ce ll values as a ratio to obtain a fo ld 
increase. Three scts of these cxperiments were performed to obtain the 
average fo ld increase :<:: SEM as shown in tlus graph. 
an tibody. As shown in Fig 8, p ervanadate stimulated ICAM-l 
p ro te in levels in a con cen tration-dependen t fas hion to a level 
similar to IFN y, with an approximately 2.S-fold increase in 
ICAM-1 p rotein expression w ith 100 J.LM pervanadate. Pe rvana-
date had no effec t o n the binding of an isotype-matched antibody 
directed aga inst vascular ce ll adhesion molecule-l (data not 
shown). 
D ISCUSSION 
In this studYI we show that a protein tyros ine p hosphatase in hibitor 
can indu ce ICAM-l gen e expression in A431, HeLa, or human 
keratinocytes by a pathway similar to that oflFN y. In particular, we 
present ev ide nce that pervanadate u tilizes the transcliption factor 
Statl to induce activation of the rCAM-1 gen e through the 
paliJldromic IFNy-response e le m ent (PIyRE). More importantly, 
we show th at pervanadate stimulates the express io n of ICAM-l 
mI~A and ceU surf.c1Ce protein, suggesting that pervanadate's 
inductio n of pI yRE complex formation leads to transcriptional 
activation of the rCAM- l gene and subsequent protein express ion . 
The importance of protein tyrosine phosphatases in IFN y-
stimul ated gene expressio n was fi rst suggested by David cl nl 
(1993), w h o sh owed that pre-treatm ent of fibrob lasts w ith pervana-
date prio r to IFNy stimul ation maintained Statl in its tyrosine-
phosphorylated state and elevated the transcription rates of GBP 
and FcyRI . We show a similar respo nse in A43 1 cells, in w hic h 
pervanadate pre-treatment e nhanced DNA-binding activ ity to the 
ICAM-l plyRE in response to IFNy. Protein tyrosin e phosphatases 
may playa role in STAT signaling by turning off the Statl signal and 
shutting down its transcrip t io nal activity. Al te rnatively, prote in 
tyros ine phosphatases may actively repress the pathway that leads to 
th e ini tia l Statl phosphorylation (Igarashi el nl, 1993; Lamb el nl, 
1994). It is not yet known w h ethe r the action of pe r vanadate in this 
system resul ts fr'OI11 the inhibition of a constitutively activated 
protei n tyrosine phosphatase or w hether it acts through the stim u-
la tion of protein tyrosin e kin ases. Pervanadate has been shown to 
stimula te the insulin receptor tyrosine kinase (Fantus el nl, 1989) , 
and the srr- f.1 mily of tyrosine kin ases such as Ick and jjlll (Evans ct nl, 
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1994). Interestingl y, enhanced DNA-binding activity of a Stat3-
related protein was recently demonstrated in fibroblasts trans-
formed by the v-Src ollcoprotein, suggesting that src kinase can 
modulate STAT signaling by directly phosphorylating STATs or 
activating JAK kinases (Yu el (//, 1995). In f.1ct, pervanadate 
treatment of HeLa cells rapidly stimulates the tyrosine phosphory-
lation of JAK1 and the IFNy receptor (Igarashi el (/ / , 1994), 
suggesting that pervanadate mediates .its effects through activation 
of JAK1. and subsequent phosphorylation of the IFNI' receptor. 
Others have shown that pervanadate mediates interleu"kin-2-signal 
transduction events through the stimulation of /ck and fYII tyrosine 
kinases without affecting the phosphorylation of JAK3 (Evans el (//, 
1994). The precise !"Ole that protein tyrosine phosphatases and/or 
src-famil y kina ses play in the STAT activation pathway remains to 
be determined. 
Stimulation of A431 cells and human keratinocytes with per-
vanadate results in the formation of a distinct complex on ICAM-I 
pIyRE that migrates similarly to the complex formed in response to 
IFNI'. Oligonucleotides corresponding to simi lar palindromic 
IFNy-response elements successfully competed for binding with 
the IFNy- and pervanadate-st1mulated complex, consistent with 
the ability of both pIyRE and the other paJjndromic GAS sites to 
bind Statl. The ISRE-containiJlg oligonucleotide from the 6-1.6 
gene (AckrilJ el (//, 1991) did not compete for binding, consistent 
with its ability to bind to the distinct multiprotein complex ofStatl, 
Stat2, and p48 (Fu el (/1, 1990). In contrast, the GAS-containing site 
from the GBP gene only minimally competed for binding with the 
IFNy- aJld pervanadate-st1mulated ICAM-1 plyRE complex. Oth-
ers have observed similar results and speculated that the GBP GAS 
site ha s very low affinity for the STAT proteins (Stre hlow et (/1, 
1993). It is interesting to note, however, that the DNA-binding 
complex that assemb les on the GBP GAS site in response to IFNI' 
has a markedly faster mobility than the complex that assembles on 
the pIyRE in response to IFNI' or pervanadate (Naik et ai, 1997), 
indicating that som e of th e proteins that bind to the pIyRE may be 
different from those that interact with the GBP GAS, as well as the 
ISRE. 
In response to various stimu li , GAS sites and palindromic plyRE 
sites have also been shown to bind to other members of the Stat 
f.mnily, such as · acute phase response f.1ctor (APRF)/Stat 3, Stat4, 
MGF/Stat 5, or lL-4/Stat6 (Ivashkiv, 1995), as well as other 
STAT-like or novel proteins (Igarashi el (/ /, 1993; Harroch el (//, 
1994; Guyer ef (/1, 1995). In our system, the complex formed on 
ICAM-1 plyRE in response to pervanadare and IFNI' contains 
Statl, but is not immunoreactive with any of the other STAT 
antibodies . Others have found the presence of novel non-STAT-
like proteins bound to palindromic GAS sites, including a 43-kDa 
protein that interacts with tbe FcyR1 pJyRE in response to IFNI' 
(Igarashi et a/, 1993) and three proteins of 98, 91, and 46 kDa that 
bind to the IRF plyRE in response to interleukin-6 (Harroch el ai, 
1994) Also, it was recently shown that two non-STAT proteins of 
approx imate ly 95 and 130 kDa interact with the plyRE found in the 
Illig gene (Guyer et (//, 1.995). It has been hypothesized that th.e 
m echanism by which specificity of gene induction by cytokines may 
occur is based on the ability of different cytokines to recruit distinct 
5T AT prote ins to the receptor complex leading to distinct ho-
modimeriza tion and/or heterodimerization interactions among 
STAT proteins and accessol'y pl"Oteins, as demonstrated by the 
IFN a/,B-response. Pervanadate, however, is able to nonspecifically 
increase overall protein tyrosine phosphOl'ylation and enter the 
STAT-signaling pathway at severa l levels and yet still form the 
sam e complex on the ICAM-1. plyRE, suggesting that specificity 
also occurs at the level of the response elem ent. 
In summary, our results impJjcate a Jjgand-independent signa l 
transduction pathway in keratinocytes that follows a pathway 
similar to that induced upon IFNI' binding to its receptor. By 
localizing tbe site of action of pervanadate, we may be able to 
identity some of the component involved in IFNy-mediated signal 
transduction in keratinocytes and other epithelial cells. Further-
more, the observation tbat pervanadate treatment leads to induc-
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tion of ICAM-l mRNA and protein ex pression indicates that this 
reagent is capable of stimulating certain physiologic responses 
normally associated with cytokine-activation programs. A compar-
ison of the molecular mechani sms invo lved ill tbe regulation of 
ICAM-l expression by pervanadate and IFNI' may provide us with 
greater clues to the mechanisms involved in the regulated expres-
sion of this adhesion molecule, which is critically involved in 
cutaneous immune responses and infl ammation. 
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